Connor, Clark & Lunn Investment Management (CC&L)’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $39.3M | Sell |
|
|||||
|
2025
Q2 | $30.3M | Sell |
|
|||||
|
2025
Q1 | $33.9M | Sell |
|
|||||
|
2024
Q4 | $31.9M | Buy |
|
|||||
|
2024
Q3 | $15.3M | Sell |
|
|||||
|
2024
Q2 | $23.3M | Sell |
|
|||||
|
2024
Q1 | $25M | Buy |
|
|||||
|
2023
Q4 | $12.5M | Buy |
|
|||||
|
2023
Q3 | $7.55M | Sell |
|
|||||
|
2023
Q2 | $15.2M | Sell |
|
|||||
|
2023
Q1 | $16.6M | Buy |
|
|||||
|
2022
Q4 | $17.5M | Buy |
|
|||||
|
2022
Q3 | $1.62M | Buy |
|
|||||
|
2022
Q2 | $481K | Buy |
|
|||||
|
2022
Q1 | $329K | Sell |
|
|||||
|
2021
Q4 | $377K | Buy |
|
|||||
|
2021
Q3 | $205K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $750K | Sell |
|
|||||
|
2018
Q3 | $1.81M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $98K | Hold |
|
|||||
|
2016
Q1 | $90K | Hold |
|
|||||
|
2015
Q4 | $132K | Buy |
|
|||||
|
2015
Q3 | $410K | Buy |
|
|||||
|
2015
Q2 | $235K | Sell |
|
|||||
|
2015
Q1 | $233K | Hold |
|
|||||
|
2014
Q4 | $318K | Buy |
|
|||||
|
2014
Q3 | $268K | Buy |
|